Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Randolph Fugit

Concepts (65)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimicrobial Stewardship
1
2023
94
0.750
Why?
Sepsis
1
2023
508
0.580
Why?
Enoxaparin
1
2022
52
0.190
Why?
Lovastatin
1
2000
26
0.180
Why?
Simvastatin
1
2000
59
0.180
Why?
Hyperlipidemias
1
2000
122
0.170
Why?
Bacteremia
1
2020
159
0.160
Why?
Collateral Circulation
1
2017
19
0.140
Why?
Ambulatory Care
1
2000
479
0.140
Why?
Anti-Bacterial Agents
2
2023
1477
0.140
Why?
Vena Cava, Inferior
1
2017
56
0.140
Why?
Acute Pain
1
2017
35
0.130
Why?
Vascular Malformations
1
2017
47
0.130
Why?
Edema
1
2017
119
0.130
Why?
Low Back Pain
1
2017
95
0.130
Why?
Venous Thrombosis
1
2017
142
0.120
Why?
Warfarin
2
2005
135
0.110
Why?
Anti-Infective Agents
2
2006
225
0.110
Why?
Biomarkers
1
2023
3418
0.110
Why?
Anticoagulants
2
2005
547
0.090
Why?
Levofloxacin
2
2005
22
0.070
Why?
International Normalized Ratio
2
2005
45
0.070
Why?
Ofloxacin
2
2005
22
0.070
Why?
Fluoroquinolones
1
2006
41
0.070
Why?
Drug Resistance, Bacterial
1
2006
155
0.060
Why?
Streptococcus pneumoniae
1
2006
134
0.060
Why?
Adult
3
2023
30608
0.060
Why?
Angina, Unstable
1
2004
72
0.060
Why?
Platelet Aggregation Inhibitors
2
2005
400
0.060
Why?
Humans
9
2023
114937
0.050
Why?
Serine Endopeptidases
1
2022
102
0.050
Why?
New Mexico
1
2000
59
0.050
Why?
HEK293 Cells
1
2022
593
0.040
Why?
Pharmacy Service, Hospital
1
2000
84
0.040
Why?
Prospective Studies
2
2020
6218
0.040
Why?
Hospitals, Veterans
1
2000
244
0.040
Why?
Pulmonary Disease, Chronic Obstructive
1
2006
928
0.040
Why?
Myocardial Infarction
1
2004
929
0.040
Why?
Inpatients
1
2020
380
0.040
Why?
Wheelchairs
1
2017
16
0.040
Why?
Mobility Limitation
1
2017
60
0.030
Why?
Dose-Response Relationship, Drug
1
2000
1856
0.030
Why?
Cohort Studies
2
2020
4903
0.030
Why?
Leg
1
2017
225
0.030
Why?
Drug Interactions
2
2005
347
0.030
Why?
Aged
4
2006
19122
0.030
Why?
Liver
1
2000
1634
0.030
Why?
Blood Glucose
1
2000
1821
0.020
Why?
Drug Therapy, Combination
2
2004
954
0.020
Why?
Male
5
2017
55663
0.020
Why?
Retrospective Studies
2
2020
12544
0.020
Why?
Tomography, X-Ray Computed
1
2017
2326
0.020
Why?
Treatment Outcome
1
2020
9105
0.020
Why?
Prazosin
1
2005
26
0.020
Why?
Pneumococcal Infections
1
2006
91
0.020
Why?
Microbial Sensitivity Tests
1
2006
301
0.020
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2005
39
0.020
Why?
Azithromycin
1
2005
80
0.010
Why?
Syndrome
1
2004
336
0.010
Why?
Administration, Oral
1
2005
731
0.010
Why?
Tobacco Use Disorder
1
2004
234
0.010
Why?
Female
3
2005
59581
0.010
Why?
Mutation
1
2006
3354
0.010
Why?
Diabetes Mellitus, Type 2
1
2004
2096
0.010
Why?
Middle Aged
1
2004
26806
0.000
Why?
Fugit's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)